CitraClear
Pre-clinical- Indications
- Diagnostic imaging
Company intelligence / Profile preview
Bracco Diagnostics is a global leader in diagnostic imaging with a broad commercial portfolio of contrast agents and medical devices for X-ray/CT, MRI, ultrasound, and nuclear medicine. The company has received multiple FDA approvals for new products and expanded indications in recent years. It continues to invest in R&D with several new product launches expected over the next two years[1][5][6].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bracco Diagnostics Inc..